ECB-ART-50936
Life (Basel)
2022 Jul 28;128:. doi: 10.3390/life12081145.
Show Gene links
Show Anatomy links
The Repertoire of Tissue Inhibitors of Metalloproteases: Evolution, Regulation of Extracellular Matrix Proteolysis, Engineering and Therapeutic Challenges.
Costa S
,
Ragusa MA
,
Lo Buglio G
,
Scilabra SD
,
Nicosia A
.
???displayArticle.abstract???
Tissue inhibitors of metalloproteases (TIMPs) belong to a fascinating protein family expressed in all Metazoa. They act as regulators of the turnover of the extracellular matrix, and they are consistently involved in essential processes. Herein, we recapitulate the main activities of mammalian TIMPs (TIMP1-4) in the control of extracellular-matrix degradation and pathologies associated with aberrant proteostasis. We delineate the activity of TIMPs in the control of extracellular matrix (ECM) homeostasis and discuss the diversity of TIMPs across metazoans taking into account the emergence of the components of the ECM during evolution. Thus, the TIMP repertoire herein analysed includes the homologues from cnidarians, which are coeval with the origins of ECM components; protostomes (molluscs, arthropods and nematodes); and deuterostomes (echinoderms and vertebrates). Several questions, including the maintenance of the structure despite low sequence similarity and the strategies for TIMP engineering, shed light on the possibility to use recombinant TIMPs integrating unique features and binding selectivity for therapeutic applications in the treatment of inflammatory pathologies.
???displayArticle.pubmedLink??? 36013323
???displayArticle.pmcLink??? PMC9409782
???displayArticle.link??? Life (Basel)
???attribute.lit??? ???displayArticles.show???
|
|
|
Figure 1. Eumetazoa phylogeny. The diagram represents the relationships among taxa; the branch lengths do not account for evolutionary distances among species. The main taxonomic divisions are indicated as well as the appearance of the ECM toolkit along with its evolution [10]. |
|
Figure 2. NJ phylogenetic tree based on the TIMPs from cnidarians to vertebrates. The tree was generated using MEGA X. All the sequences used were obtained from GenBank at National Centre for Biotechnology Information (NCBI). The p-distance model was used to construct the phylogenetic tree. Internal branches were assessed using 1000 bootstrap replications. Bootstrap values greater than 40% are indicated at the nodes. Gene nomenclature is according to [10]. The main taxonomic divisions are indicated. Single- and double-domain TIMPs are shown next to the corresponding groups Different colors represent TIMPs clustering according to isoforms in vertebrates. |
References [+] :
Amour,
The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3.
2000, Pubmed
Amour, The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3. 2000, Pubmed
Arkadash, Combinatorial engineering of N-TIMP2 variants that selectively inhibit MMP9 and MMP14 function in the cell. 2018, Pubmed
Arkadash, Development of High Affinity and High Specificity Inhibitors of Matrix Metalloproteinase 14 through Computational Design and Directed Evolution. 2017, Pubmed
Bahudhanapati, Phage display of tissue inhibitor of metalloproteinases-2 (TIMP-2): identification of selective inhibitors of collagenase-1 (metalloproteinase 1 (MMP-1)). 2011, Pubmed
Baker, Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3. 1999, Pubmed
Ball, A simple plan--cnidarians and the origins of developmental mechanisms. 2004, Pubmed
Barski, Hypermethylation and transcriptional downregulation of the TIMP3 gene is associated with allelic loss on 22q12.3 and malignancy in meningiomas. 2010, Pubmed
Bloom, Structural determinants of the rate of protein evolution in yeast. 2006, Pubmed
Bode, Axial patterning in hydra. 2009, Pubmed
Bosch, Why polyps regenerate and we don't: towards a cellular and molecular framework for Hydra regeneration. 2007, Pubmed
Brew, The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. 2010, Pubmed
Brew, Tissue inhibitors of metalloproteinases: evolution, structure and function. 2000, Pubmed
Carreca, TIMP-3 facilitates binding of target metalloproteinases to the endocytic receptor LRP-1 and promotes scavenging of MMP-1. 2020, Pubmed
Conway Morris, Darwin's dilemma: the realities of the Cambrian 'explosion'. 2006, Pubmed
D'Angelo, TIMP-1 via TWIST1 induces EMT phenotypes in human breast epithelial cells. 2014, Pubmed
Davidsen, TIMP-1 gene deficiency increases tumour cell sensitivity to chemotherapy-induced apoptosis. 2006, Pubmed
Doherty, Engineered Tissue Inhibitor of Metalloproteinases-3 Variants Resistant to Endocytosis Have Prolonged Chondroprotective Activity. 2016, Pubmed
Duan, Expanding the Activity of Tissue Inhibitors of Metalloproteinase (TIMP)-1 against Surface-Anchored Metalloproteinases by the Replacement of Its C-Terminal Domain: Implications for Anti-Cancer Effects. 2015, Pubmed
Egeblad, New functions for the matrix metalloproteinases in cancer progression. 2002, Pubmed
Escalona, TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells. 2020, Pubmed
Esposito, Effect of calcineurin inhibitors on extracellular matrix turnover in isolated human glomeruli. 2004, Pubmed
Fernandez, The anti-angiogenic peptide, loop 6, binds insulin-like growth factor-1 receptor. 2010, Pubmed
Fields, The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma. 2019, Pubmed
Franzosa, Structural determinants of protein evolution are context-sensitive at the residue level. 2009, Pubmed
Fujisawa, Hydra regeneration and epitheliopeptides. 2003, Pubmed
Georgescu, Decreased metalloprotease 9 induction, cardiac fibrosis, and higher autophagy after pressure overload in mice lacking the transcriptional regulator p8. 2011, Pubmed
Goldman, Assessing the impact of secondary structure and solvent accessibility on protein evolution. 1998, Pubmed
Gu, Frequent loss of TIMP-3 expression in progression of esophageal and gastric adenocarcinomas. 2008, Pubmed
Hamze, Constraining specificity in the N-domain of tissue inhibitor of metalloproteinases-1; gelatinase-selective inhibitors. 2007, Pubmed
Han, Global properties of the mapping between local amino acid sequence and local structure in proteins. 1996, Pubmed
Hekmat, TIMP-1 increases expression and phosphorylation of proteins associated with drug resistance in breast cancer cells. 2013, Pubmed
Hoegy, Tissue inhibitor of metalloproteinases-2 (TIMP-2) suppresses TKR-growth factor signaling independent of metalloproteinase inhibition. 2001, Pubmed
Huang, Mutational study of the amino-terminal domain of human tissue inhibitor of metalloproteinases 1 (TIMP-1) locates an inhibitory region for matrix metalloproteinases. 1997, Pubmed
Hynes, The extracellular matrix: not just pretty fibrils. 2009, Pubmed
Iyer, Crystal structure of the catalytic domain of matrix metalloproteinase-1 in complex with the inhibitory domain of tissue inhibitor of metalloproteinase-1. 2007, Pubmed
Jiang, Targeting a Designer TIMP-1 to the Cell Surface for Effective MT1-MMP Inhibition: A Potential Role for the Prion Protein in Renal Carcinoma Therapy. 2019, Pubmed
Jung, Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein. 2006, Pubmed
Kandalam, TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation. 2010, Pubmed
Kashiwagi, TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5). 2001, Pubmed
Kubota, Occurrence of two distinct types of tissue inhibitor of metalloproteinases-2 in teleost fish. 2003, Pubmed
Kuvaja, High preoperative plasma TIMP-1 is prognostic for early relapse in primary breast carcinoma. 2008, Pubmed
Lee, Unveiling the surface epitopes that render tissue inhibitor of metalloproteinase-1 inactive against membrane type 1-matrix metalloproteinase. 2003, Pubmed
Leontovich, A novel hydra matrix metalloproteinase (HMMP) functions in extracellular matrix degradation, morphogenesis and the maintenance of differentiated cells in the foot process. 2000, Pubmed
Levin, Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects. 2017, Pubmed
Lieu, Impaired remodeling phase of fracture repair in the absence of matrix metalloproteinase-2. 2011, Pubmed
Liu, Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells against intrinsic apoptotic cell death via the focal adhesion kinase/phosphatidylinositol 3-kinase and MAPK signaling pathway. 2003, Pubmed
Lizarraga, Tissue inhibitor of metalloproteinases-4 (TIMP-4) regulates stemness in cervical cancer cells. 2016, Pubmed
Mahmoodi, Lack of tissue inhibitor of metalloproteinases-3 results in an enhanced inflammatory response in antigen-induced arthritis. 2005, Pubmed
Martindale, The Radiata and the evolutionary origins of the bilaterian body plan. 2002, Pubmed
Maskos, Flexibility and variability of TIMP binding: X-ray structure of the complex between collagenase-3/MMP-13 and TIMP-2. 2007, Pubmed
Masson, Loss of expression of TIMP3 in clear cell renal cell carcinoma. 2010, Pubmed
McCawley, Matrix metalloproteinases: they're not just for matrix anymore! 2001, Pubmed
Mizuguchi, Analysis of conservation and substitutions of secondary structure elements within protein superfamilies. 2000, Pubmed
Montagnani, First evidence of the activation of Cg-timp, an immune response component of Pacific oysters, through a damage-associated molecular pattern pathway. 2007, Pubmed
Moya, The transcriptomic response to thermal stress is immediate, transient and potentiated by ultraviolet radiation in the sea anemone Anemonia viridis. 2012, Pubmed
Murphy, Tissue inhibitors of metalloproteinases. 2011, Pubmed
Murphy, Progress in matrix metalloproteinase research. 2008, Pubmed
Murphy, Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair? 2008, Pubmed
Nicosia, Maintenance of a Protein Structure in the Dynamic Evolution of TIMPs over 600 Million Years. 2016, Pubmed
Okamoto, Activation of human matrix metalloproteinases by various bacterial proteinases. 1997, Pubmed
Overington, Environment-specific amino acid substitution tables: tertiary templates and prediction of protein folds. 1992, Pubmed
Parks, Matrix metalloproteinases as modulators of inflammation and innate immunity. 2004, Pubmed
Peeney, TIMP-2 suppresses tumor growth and metastasis in murine model of triple-negative breast cancer. 2020, Pubmed
Pohar, Invertebrate tissue inhibitor of metalloproteinase: structure and nested gene organization within the synapsin locus is conserved from Drosophila to human. 1999, Pubmed
Pushpakumar, Angiotensin-II induced hypertension and renovascular remodelling in tissue inhibitor of metalloproteinase 2 knockout mice. 2013, Pubmed
Raeeszadeh-Sarmazdeh, Directed evolution of the metalloproteinase inhibitor TIMP-1 reveals that its N- and C-terminal domains cooperate in matrix metalloproteinase recognition. 2019, Pubmed
Ratajczak-Wielgomas, Expression of MMP-2, TIMP-2, TGF-β1, and decorin in Dupuytren's contracture. 2012, Pubmed
Roten, Effects of gene deletion of the tissue inhibitor of the matrix metalloproteinase-type 1 (TIMP-1) on left ventricular geometry and function in mice. 2000, Pubmed
Sahebjam, Increased collagen and aggrecan degradation with age in the joints of Timp3(-/-) mice. 2007, Pubmed
Sarras, Hydra and Niccolo Paganini (1782-1840)--two peas in a pod? The molecular basis of extracellular matrix structure in the invertebrate, Hydra. 2001, Pubmed
Sarras, Components, structure, biogenesis and function of the Hydra extracellular matrix in regeneration, pattern formation and cell differentiation. 2012, Pubmed
Seipel, Evolution of striated muscle: jellyfish and the origin of triploblasty. 2005, Pubmed
Selman, TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment? 2000, Pubmed
Seo, TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. 2003, Pubmed
Sharabi, Affinity- and specificity-enhancing mutations are frequent in multispecific interactions between TIMP2 and MMPs. 2014, Pubmed
Shimizu, The extracellular matrix of hydra is a porous sheet and contains type IV collagen. 2008, Pubmed
Sitbon, Occurrence of protein structure elements in conserved sequence regions. 2007, Pubmed
Spanò, Tissue Inhibitor of Metalloproteases 3 (TIMP-3): In Vivo Analysis Underpins Its Role as a Master Regulator of Ectodomain Shedding. 2022, Pubmed
Su, TIMP-3 as a therapeutic target for cancer. 2019, Pubmed
Takawale, Myocardial overexpression of TIMP3 after myocardial infarction exerts beneficial effects by promoting angiogenesis and suppressing early proteolysis. 2017, Pubmed
Technau, Evolutionary crossroads in developmental biology: Cnidaria. 2011, Pubmed
Ulrich, Expression of matrix metalloproteinases and their inhibitors in cords and nodules of patients with Dupuytren's disease. 2009, Pubmed
Wang, A novel tissue inhibitor of metalloproteinase in blood clam Tegillarca granosa: molecular cloning, tissue distribution and expression analysis. 2012, Pubmed
Warner, Establishment of Structure-Function Relationship of Tissue Inhibitor of Metalloproteinase-1 for Its Interaction with CD63: Implication for Cancer Therapy. 2020, Pubmed
Wei, Protein engineering of the tissue inhibitor of metalloproteinase 1 (TIMP-1) inhibitory domain. In search of selective matrix metalloproteinase inhibitors. 2003, Pubmed
Wild, Frequent methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene in pancreatic endocrine tumors. 2003, Pubmed
Xu, Cloning and characterization of TIMP-2b gene in grass carp. 2011, Pubmed
Yan, Hydra metalloproteinase 1: a secreted astacin metalloproteinase whose apical axis expression is differentially regulated during head regeneration. 2000, Pubmed
Yu, Inhibition of human leukemia xenograft in nude mice by adenovirus-mediated tissue inhibitor of metalloproteinase-3. 2006, Pubmed
Yu, Duplication, degeneration and subfunctionalization of the nested synapsin-Timp genes in Fugu. 2003, Pubmed